Prakash Gudsoorkar
@gudnephron.bsky.social
Asso Prof UCCOM I Kidneydoc | @UCKidney
Lead, OncoNeph Program
❤️ Onconeph, 🏡 dialysis, ICU Neph
Deputy Editor @KidneyNews
Editorial Board @akdhjounal @BMCNephro
⭐️wars 🤓
Fav 🏞️ : Grand Tetons
🐶🐾🦴 Dad
🇮🇳 ~> 🇨🇦 ~> 🇺🇸
Lead, OncoNeph Program
❤️ Onconeph, 🏡 dialysis, ICU Neph
Deputy Editor @KidneyNews
Editorial Board @akdhjounal @BMCNephro
⭐️wars 🤓
Fav 🏞️ : Grand Tetons
🐶🐾🦴 Dad
🇮🇳 ~> 🇨🇦 ~> 🇺🇸
Reposted by Prakash Gudsoorkar
This #ASNKidneyNews special section on green nephrology brings together insights from experts advocating responsible innovation in kidney care, balancing clinical efficacy with ecological stewardship. Explore the articles: bit.ly/KN-Green
@gudnephron.bsky.social
@gudnephron.bsky.social
May 9, 2025 at 5:20 PM
This #ASNKidneyNews special section on green nephrology brings together insights from experts advocating responsible innovation in kidney care, balancing clinical efficacy with ecological stewardship. Explore the articles: bit.ly/KN-Green
@gudnephron.bsky.social
@gudnephron.bsky.social
Reposted by Prakash Gudsoorkar
We check renin in all patients refd to the Ottawa hypertension clinic (also 24 hour urine for Na & K)
Renin phenotyping is useful - see data from @anandvaidya17.bsky.social in @ahajournals.bsky.social below
Renin phenotyping is useful - see data from @anandvaidya17.bsky.social in @ahajournals.bsky.social below
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism
#nephsky
www.ahajournals.org/doi/10.1161/...
#nephsky
www.ahajournals.org/doi/10.1161/...
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism | Hypertension
BACKGROUND: Primary aldosteronism (PA) is a distinct cause of low-renin hypertension (LRH), characterized
by inappropriate aldosterone production. We investigated the distinction between LRH
and PA by...
www.ahajournals.org
April 2, 2025 at 1:17 AM
We check renin in all patients refd to the Ottawa hypertension clinic (also 24 hour urine for Na & K)
Renin phenotyping is useful - see data from @anandvaidya17.bsky.social in @ahajournals.bsky.social below
Renin phenotyping is useful - see data from @anandvaidya17.bsky.social in @ahajournals.bsky.social below
Reposted by Prakash Gudsoorkar
Oral health is often overlooked in nephrology care, despite significant implications. Authors unveil the crosstalk between oral and kidney health. bit.ly/KN1703-18
@gudspri.bsky.social
@sujayamehta.bsky.social
@gudnephron.bsky.social
#ASNKidneyNews
@gudspri.bsky.social
@sujayamehta.bsky.social
@gudnephron.bsky.social
#ASNKidneyNews
April 2, 2025 at 1:00 PM
Oral health is often overlooked in nephrology care, despite significant implications. Authors unveil the crosstalk between oral and kidney health. bit.ly/KN1703-18
@gudspri.bsky.social
@sujayamehta.bsky.social
@gudnephron.bsky.social
#ASNKidneyNews
@gudspri.bsky.social
@sujayamehta.bsky.social
@gudnephron.bsky.social
#ASNKidneyNews
Reposted by Prakash Gudsoorkar
What are some of the common and rare indications and complications of therapeutic plasma exchange? Find out in our new study published in BMC Nephrology! 🩸https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-03970-2#citeas
@gudnephron.bsky.social
#NephSky #MedStudentSky
@gudnephron.bsky.social
#NephSky #MedStudentSky
February 21, 2025 at 7:04 PM
What are some of the common and rare indications and complications of therapeutic plasma exchange? Find out in our new study published in BMC Nephrology! 🩸https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-03970-2#citeas
@gudnephron.bsky.social
#NephSky #MedStudentSky
@gudnephron.bsky.social
#NephSky #MedStudentSky
Reposted by Prakash Gudsoorkar
Interested in Green Nephrology? Brand new paper from 🇪🇸out in CKJ on how to reduce the environmental footprint of dialysis, a “power- and water-hungry, and a waste generating intervention”
academic.oup.com/ckj/advance-...
academic.oup.com/ckj/advance-...
How to improve the environmental impact in hemodialysis: small actions, big changes
AbstractBackground and hypothesis. The burden of chronic kidney disease is increasing driven by population aging and the rising of risk factors. In-centre
academic.oup.com
December 22, 2024 at 10:35 AM
Interested in Green Nephrology? Brand new paper from 🇪🇸out in CKJ on how to reduce the environmental footprint of dialysis, a “power- and water-hungry, and a waste generating intervention”
academic.oup.com/ckj/advance-...
academic.oup.com/ckj/advance-...
December 5, 2024 at 4:56 PM
Reposted by Prakash Gudsoorkar
even the @theisn.org #ISNWCN has two high impact trial sessions!
This has to be one of the #TopNephrology stories
the era of nephrology lagging behind in RCTs is over
#NephSky
This has to be one of the #TopNephrology stories
the era of nephrology lagging behind in RCTs is over
#NephSky
December 4, 2024 at 1:44 AM
even the @theisn.org #ISNWCN has two high impact trial sessions!
This has to be one of the #TopNephrology stories
the era of nephrology lagging behind in RCTs is over
#NephSky
This has to be one of the #TopNephrology stories
the era of nephrology lagging behind in RCTs is over
#NephSky
Reposted by Prakash Gudsoorkar
RBC cast - brightfield with SM stain - from patient admitted with AKI, "pneumonia" and fatigue - serologies all negative - biopsy pending ... #UrineMicroscopy #UrinarySediment
November 29, 2024 at 1:32 AM
RBC cast - brightfield with SM stain - from patient admitted with AKI, "pneumonia" and fatigue - serologies all negative - biopsy pending ... #UrineMicroscopy #UrinarySediment
Reposted by Prakash Gudsoorkar
jamanetwork.com/journals/jam...
GLP-1 RAs may reduce the risk of cirrhosis progression and complications in patients with MASLD and DM, especially when started early. No benefit observed if initiated after cirrhosis onset. #LiverHealth #DiabetesCare #metabolicsyndrome
GLP-1 RAs may reduce the risk of cirrhosis progression and complications in patients with MASLD and DM, especially when started early. No benefit observed if initiated after cirrhosis onset. #LiverHealth #DiabetesCare #metabolicsyndrome
GLP-1 Receptor Agonists and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
This cohort study aims to determine whether use of glucagon-like peptide 1 receptor agonists are associated with lower risk of developing cirrhosis and its complications, including decompensation and ...
jamanetwork.com
November 23, 2024 at 10:45 PM
jamanetwork.com/journals/jam...
GLP-1 RAs may reduce the risk of cirrhosis progression and complications in patients with MASLD and DM, especially when started early. No benefit observed if initiated after cirrhosis onset. #LiverHealth #DiabetesCare #metabolicsyndrome
GLP-1 RAs may reduce the risk of cirrhosis progression and complications in patients with MASLD and DM, especially when started early. No benefit observed if initiated after cirrhosis onset. #LiverHealth #DiabetesCare #metabolicsyndrome
Reposted by Prakash Gudsoorkar
Wondering why vasoconstrictors work in hepatorenal syndrome even though the pathogenesis is driven by renal vasoconstriction? Here is a conceptual explanation:
November 18, 2024 at 7:15 PM
Wondering why vasoconstrictors work in hepatorenal syndrome even though the pathogenesis is driven by renal vasoconstriction? Here is a conceptual explanation:
November 18, 2024 at 4:09 AM
Reposted by Prakash Gudsoorkar
I am at the beginning of my AI journey of discovery, you know the place where you are still dumbfounded by what the machine can do. In this case it developed a pretty compelling electrolyte curriculum for nephrology fellows 😳
pbfluids.com/2024/11/ai-c...
pbfluids.com/2024/11/ai-c...
AI Curriculum
I am still in the “amazed by what AI can do” stage Here is me prompt i am teaching a class on electrolyte abnormalities for nephrologists. What would be good tricky things to teach I th…
pbfluids.com
November 17, 2024 at 6:01 AM
I am at the beginning of my AI journey of discovery, you know the place where you are still dumbfounded by what the machine can do. In this case it developed a pretty compelling electrolyte curriculum for nephrology fellows 😳
pbfluids.com/2024/11/ai-c...
pbfluids.com/2024/11/ai-c...
Reposted by Prakash Gudsoorkar
FINEARTS-HF trial in JAMA Cardiology:
Finerenone was effective in reducing the risk of CV death and heart failure events even in patients with mildly reduced or preserved ejection fraction who experienced elevated potassium levels. #AHA24
https://ja.ma/4euKMwg
Finerenone was effective in reducing the risk of CV death and heart failure events even in patients with mildly reduced or preserved ejection fraction who experienced elevated potassium levels. #AHA24
https://ja.ma/4euKMwg
November 17, 2024 at 2:55 PM
FINEARTS-HF trial in JAMA Cardiology:
Finerenone was effective in reducing the risk of CV death and heart failure events even in patients with mildly reduced or preserved ejection fraction who experienced elevated potassium levels. #AHA24
https://ja.ma/4euKMwg
Finerenone was effective in reducing the risk of CV death and heart failure events even in patients with mildly reduced or preserved ejection fraction who experienced elevated potassium levels. #AHA24
https://ja.ma/4euKMwg
Reposted by Prakash Gudsoorkar
Transition from an estimated glomerular filtration rate (eGFR)-based to a risk-based approach to CKD care from KDIGO
#Nephpearls #NephSky
👉 kdigo.org/guidelines/c...
💻 kidneyfailurerisk.com
#Nephpearls #NephSky
👉 kdigo.org/guidelines/c...
💻 kidneyfailurerisk.com
November 17, 2024 at 4:38 PM
Transition from an estimated glomerular filtration rate (eGFR)-based to a risk-based approach to CKD care from KDIGO
#Nephpearls #NephSky
👉 kdigo.org/guidelines/c...
💻 kidneyfailurerisk.com
#Nephpearls #NephSky
👉 kdigo.org/guidelines/c...
💻 kidneyfailurerisk.com
x.com/tony_breu/st...
Why iodine is used as IV contrast?
Find this excellent Xorial by @tonybreu.bsky.social
@zacharysmithmd.bsky.social
@drjakenysather.bsky.social
@jayminbpmd.bsky.social
Why iodine is used as IV contrast?
Find this excellent Xorial by @tonybreu.bsky.social
@zacharysmithmd.bsky.social
@drjakenysather.bsky.social
@jayminbpmd.bsky.social
x.com
x.com
November 17, 2024 at 1:46 PM
x.com/tony_breu/st...
Why iodine is used as IV contrast?
Find this excellent Xorial by @tonybreu.bsky.social
@zacharysmithmd.bsky.social
@drjakenysather.bsky.social
@jayminbpmd.bsky.social
Why iodine is used as IV contrast?
Find this excellent Xorial by @tonybreu.bsky.social
@zacharysmithmd.bsky.social
@drjakenysather.bsky.social
@jayminbpmd.bsky.social
November 17, 2024 at 3:11 AM
Reposted by Prakash Gudsoorkar
The discovery of the #aquaporin #AQP family of water channels has provided a molecular counterpart to the movement of water across biological membranes. This JASN review, discusses the concept of osmosis and its central relevance for #PeritonealDialysis. journals.lww.com/jasn/fulltex...
Aquaporin-1 and Osmosis: From Physiology to Precision in... : Journal of the American Society of Nephrology
ion and/or trafficking are key to sustain osmosis in multiple tissues. Here, we review the convergent evidence demonstrating that aquaporin-1 (AQP1) facilitates water transport across endothelial cell...
journals.lww.com
November 10, 2024 at 3:00 PM
The discovery of the #aquaporin #AQP family of water channels has provided a molecular counterpart to the movement of water across biological membranes. This JASN review, discusses the concept of osmosis and its central relevance for #PeritonealDialysis. journals.lww.com/jasn/fulltex...
Reposted by Prakash Gudsoorkar
Reposted by Prakash Gudsoorkar
Healthcare staff shortages are on the rise, particularly for
#PD nurses.
👉 **Challenging question:**
Does offering staff-assisted PD help with nurse shortages?
@ispd1.bsky.social @askrenal.bsky.social @nephjc.bsky.social
Let's think 🤔 🧵 #NephSky
pubmed.ncbi.nlm.nih.gov/34411685/
#PD nurses.
👉 **Challenging question:**
Does offering staff-assisted PD help with nurse shortages?
@ispd1.bsky.social @askrenal.bsky.social @nephjc.bsky.social
Let's think 🤔 🧵 #NephSky
pubmed.ncbi.nlm.nih.gov/34411685/
The Nephrology Nursing Shortage: Insights From a Pandemic - PubMed
The Nephrology Nursing Shortage: Insights From a Pandemic
pubmed.ncbi.nlm.nih.gov
November 16, 2024 at 9:29 AM
Healthcare staff shortages are on the rise, particularly for
#PD nurses.
👉 **Challenging question:**
Does offering staff-assisted PD help with nurse shortages?
@ispd1.bsky.social @askrenal.bsky.social @nephjc.bsky.social
Let's think 🤔 🧵 #NephSky
pubmed.ncbi.nlm.nih.gov/34411685/
#PD nurses.
👉 **Challenging question:**
Does offering staff-assisted PD help with nurse shortages?
@ispd1.bsky.social @askrenal.bsky.social @nephjc.bsky.social
Let's think 🤔 🧵 #NephSky
pubmed.ncbi.nlm.nih.gov/34411685/
Reposted by Prakash Gudsoorkar
#Tirzepatide for #HFpEF & Obesity
#SUMMIT Trial
www.nejm.org/doi/full/10....
#NEJM #AHA24 #CardioSky #MedSky
@ahascience.bsky.social @dramitkhera.bsky.social
#SUMMIT Trial
www.nejm.org/doi/full/10....
#NEJM #AHA24 #CardioSky #MedSky
@ahascience.bsky.social @dramitkhera.bsky.social
November 16, 2024 at 9:50 PM
Reposted by Prakash Gudsoorkar
Follow all our monthly #GN chats at www.nephronpower.com/p/gn-chat.html
GN Chat
The Glomerular Center of Northwell now runs a special monthly GN chat to discuss fun and interesting case based discussions of glomerular ...
www.nephronpower.com
November 16, 2024 at 6:08 PM
Follow all our monthly #GN chats at www.nephronpower.com/p/gn-chat.html
Reposted by Prakash Gudsoorkar
and welcome to @drwanpen.bsky.social and @niruramkumar.bsky.social as well to the hypertension nerds starter pack!
go.bsky.app/KBLojr
go.bsky.app/KBLojr
November 15, 2024 at 7:45 PM